Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Medical Imaging (Bellingham, Wash.)
|
August 23, 2021
Lung nodule malignancy classification with weakly supervised explanation generation
Aniket Joshi, Jayanthi Sivaswamy, Gopal Datt Joshi
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 7, 2007
Improving PET receptor binding estimates from Logan plots using principal component analysis
Aniket Joshi, Jeffrey A Fessler, Robert A Koeppe
Neuroimage
|
May 22, 2009
Reducing between scanner differences in multi-center PET studies
Aniket Joshi, Robert A Koeppe, Jeffrey A Fessler
EJNMMI Research
|
February 14, 2018
Statistical evaluation of test-retest studies in PET brain imaging
Richard Baumgartner, Aniket Joshi, Dai Feng, et al.
Journal of Clinical Medicine
|
February 13, 2025
Point-of-Care Diagnosis of Atrophic Gastritis by Serological Biomarker Test (GastroPanel<sup>®</sup> Quick Test) in Gastroscopy Referral Patients in India
Mohinish Chhabra, Ajit Kolatkar, Suresh Chawla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2005
11C-DTBZ and 18F-FDG PET measures in differentiating dementias
Robert A Koeppe, Sid Gilman, Aniket Joshi, et al.
Annals of the American Thoracic Society
|
August 22, 2024
Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2-5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2, Open-Label Clinical Trial
Mirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Annals of the American Thoracic Society
|
March 21, 2023
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2 Placebo-controlled Clinical Trial
Mirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 17, 2015
Discovery of [¹¹C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors
Christopher D Cox, Eric D Hostetler, Broc A Flores, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2015
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia
Izzat T Raheem, John D Schreier, Joy Fuerst, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Medical Imaging (Bellingham, Wash.)
|
August 23, 2021
Lung nodule malignancy classification with weakly supervised explanation generation
Aniket Joshi, Jayanthi Sivaswamy, Gopal Datt Joshi
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 7, 2007
Improving PET receptor binding estimates from Logan plots using principal component analysis
Aniket Joshi, Jeffrey A Fessler, Robert A Koeppe
Neuroimage
|
May 22, 2009
Reducing between scanner differences in multi-center PET studies
Aniket Joshi, Robert A Koeppe, Jeffrey A Fessler
EJNMMI Research
|
February 14, 2018
Statistical evaluation of test-retest studies in PET brain imaging
Richard Baumgartner, Aniket Joshi, Dai Feng, et al.
Journal of Clinical Medicine
|
February 13, 2025
Point-of-Care Diagnosis of Atrophic Gastritis by Serological Biomarker Test (GastroPanel<sup>®</sup> Quick Test) in Gastroscopy Referral Patients in India
Mohinish Chhabra, Ajit Kolatkar, Suresh Chawla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2005
11C-DTBZ and 18F-FDG PET measures in differentiating dementias
Robert A Koeppe, Sid Gilman, Aniket Joshi, et al.
Annals of the American Thoracic Society
|
August 22, 2024
Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2-5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2, Open-Label Clinical Trial
Mirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Annals of the American Thoracic Society
|
March 21, 2023
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2 Placebo-controlled Clinical Trial
Mirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 17, 2015
Discovery of [¹¹C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors
Christopher D Cox, Eric D Hostetler, Broc A Flores, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2015
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia
Izzat T Raheem, John D Schreier, Joy Fuerst, et al.
Page
of 2